Edgewise Therapeutics, Inc. Share Price
EWTXEdgewise Therapeutics, Inc. Stock Performance
Open $20.82 | Prev. Close $20.86 | Circuit Range N/A |
Day Range $20.38 - $21.36 | Year Range $10.60 - $35.98 | Volume 1,01,778 |
Average Traded $21.03 |
Edgewise Therapeutics, Inc. Share Price Chart
About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.
Edgewise Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $20.82 | $21.18 | +0.00% |
12-Nov-25 | $20.82 | $21.18 | -1.74% |
11-Nov-25 | $18.41 | $21.55 | +17.79% |
10-Nov-25 | $17.20 | $18.30 | +6.83% |
07-Nov-25 | $16.98 | $17.13 | +0.18% |
06-Nov-25 | $17.88 | $17.10 | -1.50% |
05-Nov-25 | $17.21 | $17.36 | +0.49% |
FAQs on Edgewise Therapeutics, Inc. Share Price
Can I buy Edgewise Therapeutics, Inc. shares in India?
What is the share price of Edgewise Therapeutics, Inc.?
What is the 5 year returns of Edgewise Therapeutics, Inc.?
What are the high & low stock price of Edgewise Therapeutics, Inc. today?
What is the 52-week high and low of Edgewise Therapeutics, Inc. stock?